{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:58:40Z","timestamp":1781053120848,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017501","name":"Science Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2026MSXM159"],"award-info":[{"award-number":["2026MSXM159"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["cstc2019jcyj-msxmX0364"],"award-info":[{"award-number":["cstc2019jcyj-msxmX0364"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX1221"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX1221"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbih.2026.101238","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T17:07:10Z","timestamp":1776013630000},"page":"101238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploring the role of PD-1 as a marker in drug-refractory epilepsy and its potential indication for valproic acid treatment"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4224-3575","authenticated-orcid":false,"given":"Hong","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbih.2026.101238_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.annemergmed.2024.02.018","article-title":"Clinical policy: critical issues in the management of adult patients presenting to the emergency department with seizures: approved by the ACEP board of directors, April 17, 2024 (practice guideline)","volume":"84","year":"2024","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.bbih.2026.101238_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2016.12.057","article-title":"Valproic acid and ASK1 deficiency ameliorate optic neuritis and neurodegeneration in an animal model of multiple sclerosis","volume":"639","author":"Azuchi","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbih.2026.101238_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-444-64148-9.00011-9","article-title":"Epilepsy","volume":"174","author":"Bastos","year":"2020","journal-title":"Handb. Clin. Neurol."},{"issue":"18","key":"10.1016\/j.bbih.2026.101238_bib5","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and biochemical aspects of the PD-1 checkpoint pathway","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"45","key":"10.1016\/j.bbih.2026.101238_bib6","first-page":"909","article-title":"Epilepsy in adults and access to care\u2014United states, 2010","volume":"61","year":"2012","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"2","key":"10.1016\/j.bbih.2026.101238_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/epi.16813","article-title":"First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG\/Rij rat","volume":"62","author":"Citraro","year":"2021","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.bbih.2026.101238_bib8","first-page":"11","article-title":"Intravenous valproic acid administration in status epilepticus","volume":"32","author":"Czapinski","year":"1998","journal-title":"Neurol. Neurochir. Pol."},{"issue":"1","key":"10.1016\/j.bbih.2026.101238_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50542-0","article-title":"Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy","volume":"9","author":"De Caro","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbih.2026.101238_bib10","series-title":"Jasper's Basic Mechanisms of the Epilepsies","article-title":"Neuroinflammation in epilepsy: cellular and molecular mechanisms","author":"Dingledine","year":"2024"},{"issue":"1","key":"10.1016\/j.bbih.2026.101238_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4049\/jimmunol.174.1.155","article-title":"Uncoupling of IL-2 signaling from cell cycle progression in naive CD4+ T cells by regulatory CD4+CD25+ T lymphocytes","volume":"174","author":"Duthoit","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bbih.2026.101238_bib12","first-page":"240","article-title":"Behavior-immunity relationship: the role of cytokines","volume":"53","author":"Espinosa","year":"2001","journal-title":"Rev. Invest. Clin."},{"issue":"1","key":"10.1016\/j.bbih.2026.101238_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.molimm.2012.12.009","article-title":"Leukocyte trafficking mechanisms in epilepsy","volume":"55","author":"Fabene","year":"2013","journal-title":"Mol. Immunol."},{"issue":"24","key":"10.1016\/j.bbih.2026.101238_bib14","doi-asserted-by":"crossref","first-page":"e3221","DOI":"10.1212\/WNL.0000000000010862","article-title":"The costs of epilepsy in Australia: a productivity-based analysis","volume":"95","author":"Foster","year":"2020","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.bbih.2026.101238_bib15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3390\/children9101506","article-title":"Alterations of plasma pro-inflammatory cytokine levels in children with refractory epilepsies","volume":"9","author":"Gakharia","year":"2022","journal-title":"Children"},{"issue":"5","key":"10.1016\/j.bbih.2026.101238_bib16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Epilepsy collaborators. Global, regional, and national burden of neurological disorders, 1990-2016:a systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.bbih.2026.101238_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.autrev.2015.11.007","article-title":"Autoimmune epilepsy","volume":"15","author":"Greco","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.bbih.2026.101238_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1212\/cont.0000000000001530","article-title":"First seizures, acute repetitive seizures, and status epilepticus","volume":"31","author":"Hopp","year":"2025","journal-title":"Continuum"},{"issue":"2\u20133","key":"10.1016\/j.bbih.2026.101238_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eplepsyres.2004.04.007","article-title":"The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patients","volume":"59","author":"Hulkkonen","year":"2004","journal-title":"Epilepsy Res."},{"issue":"1\u20132","key":"10.1016\/j.bbih.2026.101238_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.bbih.2026.101238_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2589","article-title":"The burden of epilepsy and unmet need in people with focal seizures","volume":"12","author":"Ioannou","year":"2022","journal-title":"Brain Behav"},{"issue":"11","key":"10.1016\/j.bbih.2026.101238_bib22","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bbih.2026.101238_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12985-016-0626-z","article-title":"Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17\/Treg imbalance","volume":"13","author":"Jin","year":"2016","journal-title":"Virol. J."},{"issue":"6","key":"10.1016\/j.bbih.2026.101238_bib24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbih.2026.101238_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yebeh.2014.05.031","article-title":"The consequences of refractory epilepsy and its treatment","volume":"37","author":"Laxer","year":"2014","journal-title":"Epilepsy Behav."},{"issue":"1\u20132","key":"10.1016\/j.bbih.2026.101238_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneuroim.2004.01.024","article-title":"Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration","volume":"152","author":"Lehtimaki","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.bbih.2026.101238_bib27","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/jcp.25604","article-title":"Valproic acid and lithium mediate anti-inflammatory effects by differentially modulating dendritic cell differentiation and function","volume":"232","author":"Leu","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.bbih.2026.101238_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.seizure.2013.03.006","article-title":"Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes","volume":"22","author":"Li","year":"2013","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.bbih.2026.101238_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1212\/01.WNL.0000149527.47600.5A","article-title":"Efficacy of rapid IV administration of valproic acid for status epilepticus","volume":"64","author":"Limdi","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.bbih.2026.101238_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/ph14050475","article-title":"Valproic acid suppresses autoimmune recurrence and allograft rejection in islet transplantation through induction of the differentiation of regulatory T cells and can be used in cell therapy for type 1 diabetes","volume":"14","author":"Lin","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbih.2026.101238_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41522-018-0073-2","article-title":"The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy","volume":"5","author":"Lindefeldt","year":"2019","journal-title":"npj Biofilms Microbiomes"},{"issue":"4","key":"10.1016\/j.bbih.2026.101238_bib32","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.4049\/jimmunol.1500578","article-title":"Valproic acid ameliorates graft-versus-host disease by downregulating Th1 and Th17 cells","volume":"195","author":"Long","year":"2015","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bbih.2026.101238_bib33","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.bbih.2026.101238_bib34","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41590-025-02137-3","article-title":"IL-10 targets IRF transcription factors to suppress IFN and inflammatory response genes by epigenetic mechanisms","volume":"26","author":"Mishra","year":"2025","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.bbih.2026.101238_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(13)70003-6","article-title":"Prevalence of active convulsive epilepsy in Sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies","volume":"12","author":"Ngugi","year":"2013","journal-title":"Lancet Neurol."},{"issue":"Pt B","key":"10.1016\/j.bbih.2026.101238_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.yebeh.2016.11.012","article-title":"Cannabinoids in treatment-resistant epilepsy: a review","volume":"70","author":"O'Connell","year":"2017","journal-title":"Epilepsy Behav."},{"issue":"7","key":"10.1016\/j.bbih.2026.101238_bib37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/intimm\/dxm057","article-title":"PD-1 and PD-1 ligands: from discovery to clinical application","volume":"19","author":"Okazaki","year":"2007","journal-title":"Int. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.bbih.2026.101238_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0165-5728(95)00066-B","article-title":"Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep","volume":"60","author":"Opp","year":"1995","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.bbih.2026.101238_bib39","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/bph.15732","article-title":"Time-dependent dual effect of NLRP3 inflammasome in brain ischaemia","volume":"179","author":"Palomino-Antolin","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbih.2026.101238_bib40","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1474-4422(20)30035-1","article-title":"30 years of second-generation antiseizure medications: impact and future perspectives","volume":"19","author":"Perucca","year":"2020","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.bbih.2026.101238_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00004850-200511000-00002","article-title":"Effect of valproate on plasma levels of interleukin-6 in healthy male humans","volume":"20","author":"Shiah","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.bbih.2026.101238_bib42","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213479","article-title":"Diagnosis and management of adult status epilepticus in resource-limited settings","volume":"104","author":"Soni","year":"2025","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bbih.2026.101238_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74836-w","article-title":"Valproic acid inhibits interferon-\u03b3 production by NK cells and increases susceptibility to Listeria monocytogenes infection","volume":"10","author":"Soria-Castro","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbih.2026.101238_bib44","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/brain\/awaa362","article-title":"The association between systemic autoimmune disorders and epilepsy and its clinical implications","volume":"144","author":"Steriade","year":"2021","journal-title":"Brain"},{"issue":"10172","key":"10.1016\/j.bbih.2026.101238_bib45","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bbih.2026.101238_bib46","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2014Report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.bbih.2026.101238_bib47","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1212\/WNL.54.11.2188-a","article-title":"Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus","volume":"54","author":"Uberall","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bbih.2026.101238_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.bbih.2026.101238_bib49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","article-title":"Infections, inflammation and epilepsy","volume":"131","author":"Vezzani","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbih.2026.101238_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12987-025-00660-x","article-title":"BBB proteomic analysis reveals that complex febrile seizures in infancy enhance susceptibility to epilepsy in adulthood through dysregulation of ECM-receptor interaction signaling pathway","volume":"22","author":"Wang","year":"2025","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"10.1016\/j.bbih.2026.101238_bib51","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/epi.17237","article-title":"Methodology for classification and definition of epilepsy syndromes with list of syndromes: report of the ILAE task force on nosology and definitions","volume":"63","author":"Wirrell","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbih.2026.101238_bib52","series-title":"Epilepsy: a Public Health Imperative","year":"2019"},{"issue":"4","key":"10.1016\/j.bbih.2026.101238_bib53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jphs.2018.06.014","article-title":"Valproic acid attenuates immunosuppressive function of myeloid-derived suppressor cells","volume":"137","author":"Xie","year":"2018","journal-title":"J. Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.bbih.2026.101238_bib54","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1523\/JNEUROSCI.6210-10.2011","article-title":"Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy","volume":"31","author":"Zattoni","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbih.2026.101238_bib55","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroscience.2012.07.013","article-title":"Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats","volume":"221","author":"Zhang","year":"2012","journal-title":"Neuroscience"}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626000712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626000712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:12:04Z","timestamp":1781050324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354626000712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"alternative-id":["S2666354626000712"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101238","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the role of PD-1 as a marker in drug-refractory epilepsy and its potential indication for valproic acid treatment","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101238"}}